CAS: 1484-26-0; 3-Benzyloxyaniline

该化合物是一种有机化合物,其特点是在元点存在一种用苯氧化合物组替代的活性物质组,该化合物一般是固体或液体,视其纯度和环境条件而定,以其芳香特性而著称,有助于其稳定性和反应性;苯氧基组会增强化合物的脂性,使其与水相比在有机溶剂中更易溶解. 3-(苯氧)乙酰胺可参与各种化学反应,包括电药替代和核糖基反应,因为存在氨基和醚的功能;它经常用于有机合成,特别是在制药和农用化学物的开发中;应考虑安全因素,因为吸入或摄入后可能对健康造成危害,实验室环境应采用适当的处理程序.

结构式图片

相似化合物

24318-00-1 57181-90-5 6373-46-2

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

3-(benzyloxy)nitrobenzol N-(3-(benzyloxy)phenyl)acetamide 1-(benzyloxy)-2-chlorobenzene 3-azidophenyl benzyl ether 3-Benzyloxytrifluoromethanesulfonanilid 2-(3-Benzyloxy-phenylamino)-6-chloro-3-nitro-benzoic acid 3-(benzyloxy)-4-bromoaniline 5-(Benzyloxy)-2-bromophenylamine

合成工艺路线路线简述

    间硝基苯酚置于potassium Carbonate,一水合肼体系中,用 甲醇,N,N-二甲基甲酰胺 用作溶剂,化学反应生成3-苄氧基苯胺
    参考文献:具有抗凝活性的p1处带有4-(piperidin-1-Yl)吡啶的直接凝血酶抑制剂的合成及生物学评价
    标题:具有抗凝活性的p1处带有4-(piperidin-1-Yl)吡啶的直接凝血酶抑制剂的合成及生物学评价
    摘要:描述了一种新型的非肽类直接凝血酶抑制剂的设计和合成,该抑制剂建立在1-(吡啶-4-基)哌啶-4-羧酰胺的结构上.从显示弱的凝血酶(fiia)和xa因子(fxa)抑制活性的强碱性1-Ami基哌啶衍生物(6)开始,通过优化碱性p1和x-取代的苯基p4可显着提高抗fiia活性和人工膜通透性结合部分.结构-活性关系研究以及有用的分子建模结果使我们得以鉴定出化合物13B,该化合物表现出出色的fiia抑制作用(k I = 6 Nm),抗xa活性弱(k I= 5.64μm),并且对其他丝氨酸蛋白酶(例如胰蛋白酶)具有显着的选择性.化合物13B在低微摩尔范围内显示出体外抗凝活性,并具有显着的膜通透性.在小鼠中(离体),13B在口服给药(100 Mg.kg-1)后2 H表现出抗凝作用,与对照组相比,活化的部分凝血活酶时间(aptt)延长了43%(p <0.05).
    Doi:10.1021/jm401169A

    海关参考信息

    专利信息


    专利号:US-2024097109-A1
    优先权日:2021-02-11
    标 题:Bottom-Up, Scalable Synthesis Of Oxide-Based Sub-Nano And Nanofilaments And Nanofilament-Based Two-Dimensional Flakes And Mesoporous Powders
    发明人:BARSOUM MICHEL W; BADR HUSSEIN OSAMA
    权利人:UNIV DREXEL
    摘要:Provided are methods to convert—through a bottom-up approach—binary and ternary titanium carbides, nitrides, borides, phosphides, aluminides, and silicides into lepidocrocitic nanofilaments that in some cases self-assemble into 2D flakes by immersing them in a quaternary ammonium solution at moderate temperatures. The resulting flakes can comprise nanofilaments in cross-section, some of which nanofilaments can be few microns long in some instances.

    专利号:US-6531470-B1
    优先权日:1998-01-23
    标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

    专利号:US-8076332-B2
    优先权日:2006-12-26
    标 题:N- (2-aminophenyl) benzamide derivative having urea structure
    发明人:MOGI HIROYUKI; TAJIMA HISASHI; MISHINA NORIKO; YAMAZAKI YUSUKE; YONEDA SHINJI; WATANABE KATSUHIKO; FUJIKAWA JUNKO; YAMAMOTO MINORU
    权利人:MOGI HIROYUKI; TAJIMA HISASHI; MISHINA NORIKO; YAMAZAKI YUSUKE; YONEDA SHINJI; WATANABE KATSUHIKO; FUJIKAWA JUNKO; YAMAMOTO MINORU; SANTEN PHARMACEUTICAL CO LTD
    摘要:The present invention relates to a study on the synthesis of a novel N-(2-aminophenyl)benzamide derivative having an urea structure and represented by the general formula (1); and the utilization of a pharmacological effect of the derivative. A compound represented by the general formula (1) or a salt thereof has an effect of cellular morphological change on trabecular meshwork cells and is effective in the prevention and/or treatment of a disease considered to be related to intraocular pressure. In the formula, R 1 and R 2 represent a hydrogen atom, a lower alkyl group, or the like; R 3 represents a hydroxy group, a lower alkoxy group, a lower cycloalkyloxy group, an aryloxy group, or the like; R 4 and R 5 represent a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, or the like; X represents a lower alkylene group or the like; Y represents a single bond, a lower alkylene group, or the like; l and m represent 0, 1, 2, or the like.

    专利号:US-6562844-B2
    优先权日:1998-01-23
    标 题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

    专利号:US-6417195-B1
    优先权日:1999-02-22
    标题 :Isoquinoline derivatives and isoquinoline combinatorial libraries
    发明人:LEBL MICHAL
    权利人:LION BIOSCIENCE AG
    摘要:The present invention provides the synthesis of heterocyclic compounds based on the isoquinoline ring. More specifically, the invention provides novel isoquinoline derivatives as well as novel libraries comprised of such compounds.

    专利号:US-5874443-A
    优先权日:1995-10-19
    标 题:Isoquinoline derivatives and isoquinoline combinatorial libraries
    发明人:KIELY JOHN S; GRIFFITH MICHAEL C
    权利人:TREGA BIOSCIENCES INC
    摘要:The present invention provides the synthesis of heterocyclic compounds based on the isoquinoline ring. More specifically, the invention provides novel isoquinolines as well as novel libraries comprised of many such compounds, and methods of synthesizing the libraries.
    上海常丰生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chainpharm.com
    企业联系电话:021-61727342👤
    📞上海常丰生物医药科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:021-61727342
    手机:13611721451
    传真:021-33275302
    邮箱:sales@chainpharm.com
    通信地址: 上海金山区金瓯路188号
    邮编: 201512
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海金山区金瓯路188号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    无锡市科罕科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kinghanchem.com
    企业联系电话:13372285931👤
    📞无锡市科罕科技有限公司 ⚠️参考联系方式
    联系人:张杰
    电话:13372285931
    手机:18994988176
    传真:0510-84390386
    邮箱:sales@kinghanchem.com
    通信地址: 无锡市惠山大道1619号1316室
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:无锡市惠山大道1619号1316室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Joule, J. A., Science of Synthesis Knowledge Updates, (2018) 2, 30.
    摘要:Joule, J. A., Science of Synthesis Knowledge Updates, (2018) 2, 98.
    摘要:Tomás-Gamasa, M., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 37.
    摘要:Tomás-Gamasa, M., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 36.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知